AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial Post author:Sam Post published:January 25, 2018 Post category:BioPharma Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace You Might Also Like 1-Year old Biotech Startup LifeOmic to Create 225 Jobs at New HQ December 4, 2017 This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants March 15, 2017 <b>Grazix Animal Health, Inc.</b> Announces ???Avian???S??? Natural Supplement For Poultry. New Product Launch Aimed At Supporting Productivity In Large Poultry Operations June 12, 2017
This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants March 15, 2017
<b>Grazix Animal Health, Inc.</b> Announces ???Avian???S??? Natural Supplement For Poultry. New Product Launch Aimed At Supporting Productivity In Large Poultry Operations June 12, 2017
